Section Arrow
Quote
HLN.NYSE
- Haleon plc
Quotes are at least 15-min delayed:2024/09/21 05:43 EDT
Last
 10.52
+0.06 (+0.57%)
Day High 
10.54 
Prev. Close
10.46 
1-M High
10.755 
Volume 
4.14M 
Bid
9.72
Ask
10.64
Day Low
10.43 
Open
10.45 
1-M Low
9.775 
Market Cap 
47.63B 
Currency USD 
P/E 33.37 
%Yield 1.5 
10-SMA 10.48 
20-SMA 10.27 
50-SMA 9.7 
52-W High 10.755 
52-W Low 7.695 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
0.24/0.38
Enterprise Value
56.43B
Balance Sheet
Book Value Per Share
4.80
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
10.86B
Operating Revenue Per Share
3.16
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
VTRSViatris11.39-0.51-4.29%227.2PE
TLRYTilray Brands1.71-0.07-3.93%-- 
TEVATeva Pharmaceutical Industries Limited17.51-0.25-1.41%-- 
ELANElanco Animal Health14.07-1-6.64%-- 
IRWDIronwood Pharmaceuticals4.305-0.205-4.55%56.38PE
Quotes are at least 15-min delayed：2024/09/21 05:43 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of salesfrom global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.